BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14246542)

  • 1. THE TREATMENT OF ADVANCED CANCER WITH A COMBINATION OF 5-FLUOROURACIL, CYTOXAN, AND METHOTREXATE.
    GRADY ED
    J Med Assoc Ga; 1964 Sep; 53():285-90. PubMed ID: 14246542
    [No Abstract]   [Full Text] [Related]  

  • 2. REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU.
    GREENSPAN EM
    N Y State J Med; 1964 Oct; 64():2442-9. PubMed ID: 14209557
    [No Abstract]   [Full Text] [Related]  

  • 3. COMBINED INTRA-ARTERIAL CHEMOTHERAPY AND RADIATION TREATMENT FOR ADVANCED CERVICAL CARCINOMA. THE MCCALL TECHNIQUE AND RESULTS.
    HULKA JF; BISEL HF
    Am J Obstet Gynecol; 1965 Feb; 91():486-90. PubMed ID: 14259137
    [No Abstract]   [Full Text] [Related]  

  • 4. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS; FLETCHER WS
    Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364
    [No Abstract]   [Full Text] [Related]  

  • 5. SIDE REACTIONS TO THE CHEMOTHERAPY OF SOLID TUMORS.
    SCHROEDER JM
    GP; 1965 Apr; 31():87-91. PubMed ID: 14261261
    [No Abstract]   [Full Text] [Related]  

  • 6. CLOSED PELVIC PERFUSION: A NEW APPROACH TO THE PROBLEM OF ADVANCED GYNECOLOGIC MALIGNANCY.
    CAVANAGH D; MARTIN DS; HERNANDEZ-ROMAN P
    Am J Obstet Gynecol; 1965 Aug; 92():996-1005. PubMed ID: 14321117
    [No Abstract]   [Full Text] [Related]  

  • 7. [91 CASES OF CONTINUOUS SIMULTANEOUS POLYCHEMOTHERAPY IN INOPERABLE LUNG CANCERS].
    ISRAEL ; SORSC L; REBOUL R
    Presse Med (1893); 1965 Mar; 73():701-4. PubMed ID: 14252397
    [No Abstract]   [Full Text] [Related]  

  • 8. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 9. CLOSED PELVIC PERFUSION: ISOLATION PERFUSION OF THE PELVIS WITHOUT CELIOTOMY.
    MARTIN DS; WHITE HM; HOBBS J; KURZWEG FT; HUDSON PJ
    Surgery; 1964 Dec; 56():1056-63. PubMed ID: 14238359
    [No Abstract]   [Full Text] [Related]  

  • 10. [CHEMOTHERAPY IN TREATMENT OF CARCINOMA OF THE OVARY].
    OGIER E; MAIJNELLI M; PERITI P
    Riv Ostet Ginecol; 1964 Oct; 19():610-29. PubMed ID: 14237193
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON CONTINUOUS INTRA-HYPOGASTRIC ARTERIAL INFUSION OF ANTICARCINOGENIC AGENTS IN PATIENTS WITH CERVICAL CANCER AS A SUPPLEMENTARY THERAPY TO SURGICAL OPERATION].
    IZUCHI S
    Gan No Rinsho; 1964 Sep; 10():689-96. PubMed ID: 14209132
    [No Abstract]   [Full Text] [Related]  

  • 12. TUMORS OF THE SKIN. IV. DOUBLE-BLIND STUDY ON EFFECTS OF LOCAL ADMINISTRATION OF ANTI-TUMOR AGENTS IN BASAL CELL CARCINOMA.
    KLEIN E; STOLL HL; MILGROM H; CASE RW; TRAENKLE HL; GRAHAM S; LAOR Y; HELM F
    J Invest Dermatol; 1965 May; 44():351-3. PubMed ID: 14290308
    [No Abstract]   [Full Text] [Related]  

  • 13. BLOOD AND URINE LEVELS OF ANTITUMOR AGENTS DETERMINED WITH CELL CULTURE METHODS.
    SMITH CG; GRADY JE; KUPIECKI FP
    Cancer Res; 1965 Feb; 25():241-5. PubMed ID: 14264057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].
    Scanni A; Tomirotti M; Biraghi M; Annibali E; Del Bianco S
    Minerva Med; 1980 Mar; 71(10):799-801. PubMed ID: 7360368
    [No Abstract]   [Full Text] [Related]  

  • 15. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.
    BERENBAUM MC; BROWN IN
    Immunology; 1964 Jan; 7(1):65-71. PubMed ID: 14113077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical controlled trial in advanced breast cancer: CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CMF + T (cyclophosphamide, methotrexate, 5-fluorouracil, tamoxifen). CMEA Cooperative Treatment Group.
    Neoplasma; 1985; 32(3):381-7. PubMed ID: 2862594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 18. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREATMENT OF ACUTE LEUKEMIA: CURRENT RESULTS, AND ANALYSIS OF WHAT WE CAN DO NOW.
    SULLIVAN MP; TAYLOR G; SUTOW WW
    CA Cancer J Clin; 1964; 14():261-5. PubMed ID: 14216117
    [No Abstract]   [Full Text] [Related]  

  • 20. [REPORT ON REGIONAL CHEMOTHERAPY IN CANCEROLOGY].
    VELASCO RN
    Bol Trab Soc Cir B Aires; 1963 Sep; 47():552-4. PubMed ID: 14091333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.